Evaluation of convalescent plasma for Ebola virus disease in Guinea J Van Griensven, T Edwards, X de Lamballerie, MG Semple, P Gallian, ... New England Journal of Medicine 374 (1), 33-42, 2016 | 634 | 2016 |
Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trial A Musa, E Khalil, A Hailu, J Olobo, M Balasegaram, R Omollo, T Edwards, ... PLoS neglected tropical diseases 6 (6), e1674, 2012 | 184 | 2012 |
Active convulsive epilepsy in a rural district of Kenya: a study of prevalence and possible risk factors T Edwards, AG Scott, G Munyoki, VM Odera, E Chengo, E Bauni, T Kwasa, ... The Lancet Neurology 7 (1), 50-56, 2008 | 170 | 2008 |
Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial A Hailu, A Musa, M Wasunna, M Balasegaram, S Yifru, G Mengistu, ... PLoS neglected tropical diseases 4 (10), e709, 2010 | 161 | 2010 |
Incidence and outcome of convulsive status epilepticus in Kenyan children: a cohort study M Sadarangani, C Seaton, JAG Scott, B Ogutu, T Edwards, A Prins, ... The Lancet Neurology 7 (2), 145-150, 2008 | 160 | 2008 |
Risk factors associated with the epilepsy treatment gap in Kilifi, Kenya: a cross-sectional study CK Mbuba, AK Ngugi, G Fegan, F Ibinda, SN Muchohi, C Nyundo, ... The Lancet Neurology 11 (8), 688-696, 2012 | 153 | 2012 |
Prevalence, incidence and risk factors of epilepsy in older children in rural Kenya V Mung’ala-Odera, S White, R Meehan, GO Otieno, P Njuguna, N Mturi, ... Seizure 17 (5), 396-404, 2008 | 131 | 2008 |
Paromomycin for the treatment of visceral leishmaniasis in Sudan: a randomized, open-label, dose-finding study AM Musa, B Younis, A Fadlalla, C Royce, M Balasegaram, M Wasunna, ... PLoS neglected tropical diseases 4 (10), e855, 2010 | 124 | 2010 |
A diagnostics platform for the integrated mapping, monitoring, and surveillance of neglected tropical diseases: rationale and target product profiles AW Solomon, D Engels, RL Bailey, IM Blake, S Brooker, JX Chen, ... Public Library of Science 6 (7), e1746, 2012 | 115 | 2012 |
Gametocytaemia after drug treatment of asymptomatic Plasmodium falciparum S Dunyo, P Milligan, T Edwards, C Sutherland, G Targett, M Pinder PLoS clinical trials 1 (4), e20, 2006 | 102 | 2006 |
The use of Ebola convalescent plasma to treat Ebola virus disease in resource-constrained settings: a perspective from the field J van Griensven, A De Weiggheleire, A Delamou, PG Smith, T Edwards, ... Clinical infectious diseases 62 (1), 69-74, 2016 | 100 | 2016 |
Trachoma prevalence and associated risk factors in the gambia and Tanzania: baseline results of a cluster randomised controlled trial EM Harding-Esch, T Edwards, H Mkocha, B Munoz, MJ Holland, SE Burr, ... PLoS neglected tropical diseases 4 (11), e861, 2010 | 100 | 2010 |
Efficacy and safety of AmBisome in combination with sodium stibogluconate or miltefosine and miltefosine monotherapy for African visceral leishmaniasis: phase II randomized trial M Wasunna, S Njenga, M Balasegaram, N Alexander, R Omollo, ... PLoS neglected tropical diseases 10 (9), e0004880, 2016 | 90 | 2016 |
Safety and efficacy of single dose versus multiple doses of AmBisome® for treatment of visceral leishmaniasis in eastern Africa: a randomised trial EAG Khalil, T Weldegebreal, BM Younis, R Omollo, AM Musa, W Hailu, ... PLoS neglected tropical diseases 8 (1), e2613, 2014 | 87 | 2014 |
Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia EM Harding-Esch, A Sillah, T Edwards, SE Burr, JD Hart, H Joof, M Laye, ... PLoS neglected tropical diseases 7 (6), e2115, 2013 | 76 | 2013 |
Plasmodium infection, anaemia and mosquito net use among school children across different settings in Kenya CW Gitonga, T Edwards, PN Karanja, AM Noor, RW Snow, SJ Brooker Tropical Medicine & International Health 17 (7), 858-870, 2012 | 70 | 2012 |
Safety and efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East … R Omollo, N Alexander, T Edwards, EAG Khalil, BM Younis, AA Abuzaid, ... Trials 12 (1), 1-10, 2011 | 68 | 2011 |
Active Trachoma and Ocular Chlamydia trachomatis Infection in Two Gambian Regions: On Course for Elimination by 2020? EM Harding-Esch, T Edwards, A Sillah, I Sarr, CH Roberts, P Snell, ... PLoS neglected tropical diseases 3 (12), e573, 2009 | 66 | 2009 |
A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia E Diro, S Blesson, T Edwards, K Ritmeijer, H Fikre, H Admassu, A Kibret, ... PLoS neglected tropical diseases 13 (1), e0006988, 2019 | 62 | 2019 |
Oral amoxicillin versus benzyl penicillin for severe pneumonia among kenyan children: a pragmatic randomized controlled noninferiority trial A Agweyu, D Gathara, J Oliwa, N Muinga, T Edwards, E Allen, ... Clinical Infectious Diseases 60 (8), 1216-1224, 2015 | 62 | 2015 |